M Dimitrijevic

675 total citations
18 papers, 525 citations indexed

About

M Dimitrijevic is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M Dimitrijevic has authored 18 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Rheumatology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M Dimitrijevic's work include Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). M Dimitrijevic is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cell Adhesion Molecules Research (4 papers). M Dimitrijevic collaborates with scholars based in Serbia, Czechia and Croatia. M Dimitrijevic's co-authors include R. R. Bartlett, M Popović, Iris Löw‐Friedrich, H Seifert, Ivo Jajić, Predrag Musikic, Vibeke Strand, Z Domljan, G. Campion and Blaž Rozman and has published in prestigious journals such as Clinical & Experimental Immunology, Immunology and Inflammation Research.

In The Last Decade

M Dimitrijevic

17 papers receiving 494 citations

Peers

M Dimitrijevic

RHEUM

IMMUN

HEMAT

PFM

Haihua Gong United States

Carole Ferraro France

Caterina Baldi Italy

R. Schleyerbach Germany

Julie A. Di Paolo United States

Costakis Frangou United States

Taher E. Taher United Kingdom

Paul Guéguen France

Yuri Yanishevski United States

M. M. Tongio France

Haihua Gong United States

M Dimitrijevic

105 ×0.6

RHEUM

218 ×1.6

125 ×1.1

IMMUN

69 ×0.8

HEMAT

69 ×0.8

PFM

Citations per year, relative to M Dimitrijevic M Dimitrijevic (= 1×) peers Haihua Gong

Countries citing papers authored by M Dimitrijevic

Since Specialization

Citations

This map shows the geographic impact of M Dimitrijevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Dimitrijevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Dimitrijevic more than expected).

Fields of papers citing papers by M Dimitrijevic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Dimitrijevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Dimitrijevic. The network helps show where M Dimitrijevic may publish in the future.

Co-authorship network of co-authors of M Dimitrijevic

This figure shows the co-authorship network connecting the top 25 collaborators of M Dimitrijevic. A scholar is included among the top collaborators of M Dimitrijevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Dimitrijevic. M Dimitrijevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Stojić-Vukanić, Zorica, et al.. (2011). Differentiation and function of human monocyte-derived dendritic cells under the influence of leflunomide. Archives of Biological Sciences. 63(2). 353–364.

Dimitrijevic, M, et al.. (2003). Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP. The Hematology Journal. 4(5). 358–362. 27 indexed citations

Popović, M, et al.. (2001). Intravenous immunoglobulins in the therapy of severe bacterial infections, immunodeficiencies, and autoimmune diseases. Transplantation Proceedings. 33(3). 2376–2377. 1 indexed citations

Stojić-Vukanić, Zorica, et al.. (2001). Modulation of human peripheral blood mononuclear cell activation by the combination of leflunomide and pentoxifylline. Transplantation Proceedings. 33(3). 2137–2138. 2 indexed citations

Popovič, P., et al.. (2001). Leflunomide induces apoptosis of thymocytes and T-cell hybridoma: differences in sensitivity and signaling pathways. Transplantation Proceedings. 33(3). 2344–2346. 2 indexed citations

Popović, M, et al.. (2001). High doses of cyclophosphamide in the treatment of severe systemic lupus erythematosus. Transplantation Proceedings. 33(3). 2300–2301. 1 indexed citations

Mitrović, Dragan, et al.. (2001). Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener’s granulomatosis. Transplantation Proceedings. 33(3). 2378–2379. 1 indexed citations

Arsenović-Ranin, Nevena, Dragana Vučević, N Okada, M Dimitrijevic, & Miodrag Čolić. (2000). A monoclonal antibody to the rat Crry/p65 antigen, a complement regulatory membrane protein, stimulates adhesion and proliferation of thymocytes. Immunology. 100(3). 334–344. 10 indexed citations

Dimitrijevic, M, et al.. (1999). Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes. Clinical & Experimental Immunology. 117(1). 44–50. 17 indexed citations

10.

Popović, M, et al.. (1998). Comparative study of the clinical efficacy of four dmards (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis. Transplantation Proceedings. 30(8). 4135–4136. 19 indexed citations

11.

Mitrović, Dragan, et al.. (1998). Cyclosporine in the treatment of autoimmune disorders: a 10-year experience. Transplantation Proceedings. 30(8). 4134–4134. 2 indexed citations

12.

Dimitrijevic, M, et al.. (1998). Effects of leflunomide on experimental autoimmune myocarditis with special reference to the dendritic cells. Transplantation Proceedings. 30(8). 4149–4150. 5 indexed citations

13.

Dimitrijevic, M, et al.. (1997). The involvement of immune reactions in cardiac damage during acute myocardial infarction: role of cell-mediated immune response.. PubMed. 39(2). 85–94. 9 indexed citations

14.

Dimitrijevic, M & R. R. Bartlett. (1996). Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis. Inflammation Research. 45(11). 550–556. 21 indexed citations

15.

Dimitrijevic, M & R. R. Bartlett. (1996). Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritis.. PubMed. 28(6). 3086–7. 17 indexed citations

16.

Dimitrijevic, M, et al.. (1996). A novel immunomodulating agent--leflunomide inhibits experimental autoimmune diabetes in mice.. PubMed. 28(6). 3072–3. 8 indexed citations

17.

Domljan, Z, Blaž Rozman, Ivo Jajić, et al.. (1995). Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Arthritis & Rheumatism. 38(11). 1595–1603. 228 indexed citations

18.

Bartlett, R. R., M Dimitrijevic, Tieno Germann, et al.. (1991). Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Inflammation Research. 32(1-2). 10–21. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact